Greater access to life-changing medicine for Australians with ADHD

Australian adults living with Attention Deficit Hyperactivity Disorder (ADHD) will soon have more affordable access to a life-changing treatment option, thanks to its expanded listing on the Pharmaceutical Benefits Scheme (PBS).   On 1 February, the Government is expanding the listing of Vyvanse® (lisdexamfetamine) to include patients who are diagnosed with ADHD after they turn…

Transcript – Press Conference – Canberra

E&OE…                       Topics: suspension of travel arrangements with NZ     GREG HUNT: I’m joined by Professor Michael Kidd, the Acting Chief Medical Officer, and we’re here to report on advice from the medical expert panel, or AHPPC, received during the course of the afternoon to the Government and upon which the Government has acted.…

Pfizer vaccine approved

The Therapeutic Goods Administration (TGA) has today provisionally approved the Pfizer/BioNTech COVID-19 vaccine for use in Australia. The Pfizer vaccine has met strict standards for safety, quality and efficacy. The TGA provisional approval is for individuals 16 years of age and older. Two doses will be required – at least 21 days apart. A priority…

Mobilising Australia’s COVID-19 vaccine workforce

The Australian Government is preparing for the COVID-19 vaccine rollout by securing an additional vaccine workforce and working to deliver essential training to everyone who will administer the vaccinations.   Australia’s vaccine roll out will be carried out through hospitals, General practices, state and Commonwealth vaccination clinics, Aboriginal Community Controlled Health Organisations and Pharmacies.  …